| Andres Dario Bermudez Caba, | |
|
Torre San Cristobal Suite 303, Coto Laurel, PR 00780 | |
| (787) 813-0838 | |
| Not Available |
| Full Name | Andres Dario Bermudez Caba |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | Torre San Cristobal Suite 303, Coto Laurel, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164525705 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 11787 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital San Cristobal | Coto laurel, PR | Hospital |
| Mailing Address | Practice Location Address |
|---|---|
| Andres Dario Bermudez Caba, Po Box 1154, Coto Laurel, PR 00780-1154 Ph: () - | Andres Dario Bermudez Caba, Torre San Cristobal Suite 303, Coto Laurel, PR 00780 Ph: (787) 813-0838 |
News Archive
The U.S. Food and Drug Administration today approved Incivek treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies. Incivek is approved for use with interferon therapy made up of peginterferon alfa and ribavirin.
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Formal training in parenting strategies is a low-risk, effective method for improving behavior in preschool-age children at risk for developing attention deficit hyperactivity disorder (ADHD), while there is less evidence supporting the use of medications for children younger than 6 years old, according to a new report from the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ).
Pancreatic tumors are one of the most lethal cancers, with fewer than five percent of patients surviving five years after diagnosis. But a new study that peers deeply into the genetics of pancreatic cancer presents a bit of good news an opportunity for early diagnosis. In contrast to earlier predictions, many pancreatic tumors are, in fact, slow growing, taking nearly 20 years to become lethal after the first genetic perturbations appear.
› Verified 9 days ago
Dr. Hector Silva Rivera, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Carr. 506 Km 1.0, Torre San Cristobal Suite 408, Coto Laurel, PR 00780 Phone: 787-366-7772 | |
Dr. Ahmed Morales Jorge, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Carr #506 Plaza San Cristobal Local #3, Coto Laurel, PR 00780 Phone: 787-708-6981 Fax: 787-841-7100 | |
Dr. Helga I Rodriguez Rodriguez, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 525 Calle Castilla, Mansion Real, Coto Laurel, PR 00780 Phone: 787-922-9437 | |
Dr. Jorge E. Grillasca Palou, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 302 Torre San Cristobal, Coto Laurel, PR 00780 Phone: 787-259-1934 Fax: 787-840-7734 | |
Dr. Luis M Irizarry-pabon, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: Torre San Cristobal, Ste 209, Coto Laurel, PR 00780 Phone: 787-259-0988 | |
Dr. Jose Luis Vera-miro, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5 Ave. San Cristobal, 207 Torre San Cristobal, Coto Laurel, PR 00780 Phone: 787-842-2073 Fax: 787-842-2071 |